JubilantLife slips 4% as USFDA recommends action against plant

Shares of Jubilant Life Sciences slipped 4 percent in early trade on Monday after the US health regulator recommended a regulatory or an administrative action after the inspection of Roorkee manufacturing facility of the drug firm, according to a regulatory filing.

For more information on stock tips

and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co


Connect with our social media sites

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Follow @Epic_Research

Posted in: Indian Market Tips